by Continuous bioprocessing offers advantages such as reduction of cycle time and downtime, reduced consumption of raw materials along with lower manufacturing costs as compared to traditional batch bioprocessing. It enables a more constant and stable production with continuous product flow while optimizing facility utilization. Continuous bioprocessing helps achieve tighter process control and ensures consistent product quality.
The Continuous bioprocessing market is estimated to be valued at US$ 395 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the continuous bioprocessing market are AGC Biologics, Biogen, Bristol-Myers Squibb, Sanofi Genzyme, FUJIFILM Diosynth Biotechnologies and among others. Continuous bioprocessing offers key opportunities such as facilitating small-volume and high-value production simultaneously which helps catering to patient population effectively. Adoption of continuous bioprocessing is expected to gain traction globally with increasing need for cost-effective and flexible biomanufacturing amid rising demand for biologics.
Market Drivers
One of the major drivers for continuous bioprocessing market is lower cost of goods sold compared to batch bioprocessing. Continuous bioprocessing streamlines production process and maximizes facility utilization by allowing simultaneous small-volume and high-value productions. This significantly reduces manufacturing costs. Other drivers include flexibility to modify production in real time, tighter process control, consistent product quality and minimized downtime.
PEST Analysis
Political: The regulations around continuous bioprocessing is steadily evolving to encourage innovation and streamline product approval processes. Stringent biosafety guidelines are in place to ensure quality and safety standards.
Economic: Investments in R&D are helping drive technological advancements in continuous bioprocessing equipment and solutions. Adoption is growing due to the potential for reduced costs and improved efficiencies across the value chain.
Social: Continuous manufacturing enables on-demand production and supply of biopharmaceuticals to address unmet medical needs. It helps ensure drug security and healthcare access.
Technological: Advancements in sensors, connectivity and data science are enabling real-time process monitoring and control. Equipment designs allow for seamless transfer of cell cultures with minimized disruption. Multi-product facilities use flexible configurations for increased production capabilities.
The largest share of the continuous bioprocessing market in terms of value is concentrated in North America currently due to established biopharma industry and significant R&D investments. The Asia Pacific region is emerging as the fastest growing regional market supported by rising investments, improving regulatory guidelines and increasing development of biosimilars. Countries like China and India are expanding biomanufacturing capacities.
What Are The Key Data Covered In This Continuous Bioprocessing Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Continuous Bioprocessing’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Continuous Bioprocessing and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Continuous Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Continuous Bioprocessing vendors
FAQ’s
Q.1 What are the main factors influencing the Continuous Bioprocessing?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Continuous Bioprocessing companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Continuous Bioprocessing’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
